A-21 Effective Method to Produce Multipotential Stem Cells from Adipose Tissues
ΓùÅ Patient-Friendly: Cells are harvested from adipose tissues, not from bone marrow.ΓùÅ Wide Application: It will introduce various treatment applications.ΓùÅ Easy and Efficient: SVF is collected by centrifugation and is resistant to freeze and thaw.
ΓùÅ Treatment for ischemia disease, renal dysfunction, wounds, kidney disorders, and osteoporosisΓùÅ Research tool for regenerative medicine
None
Inventor: OZAKI, Takenori | YASUDA, Kaoru | MARUYAMA, Shouichi | YAMAMOTO, Tokunori | GOTOH, Momokazu | MATSUO, Seiichi | KITAGAWA, Yasuo
Priority Number: WO2008018450A1
IPC Current: A61K003512 | A61P000910 | A61P001312 | A61P001702 | C12N000502
Assignee Applicant: National University Corporation Nagoya University
Title: CELL PREPARATION CONTAINING MULTIPOTENTIAL STEM CELLS ORIGINATING IN FAT TISSUE | PRÉPARATION CELLULAIRE CONTENANT DES CELLULES SOUCHES MULTIPOTENTES PROVENANT D'UN TISSU ADIPEUX
Usefulness: CELL PREPARATION CONTAINING MULTIPOTENTIAL STEM CELLS ORIGINATING IN FAT TISSUE | PRÉPARATION CELLULAIRE CONTENANT DES CELLULES SOUCHES MULTIPOTENTES PROVENANT D'UN TISSU ADIPEUX
Summary: The cell formulation is useful for treating ischemic disease, renal dysfunction, wound, urinary incontinence or osteoporosis. Use of pluripotent stem cell from fat tissue and sedimented cell population for manufacturing cell formulation (claimed).
Novelty: Cell formulation useful for treating ischemic disease, renal dysfunction, wound, urinary incontinence or osteoporosis, contains pluripotent stem cells derived from fat tissue
Biomedical
Bioengineering
USA
